The influence of inflammation in the development of subclinical atherosclerosis in psoriatic arthritis: Comment on 'Cardiovascular comorbidities in patients with psoriatic arthritis: A systematic review' by Jamnistki et al

Annals of the Rheumatic Diseases

Volumn 73, Issue 5, 2014, Pages

  González Gay, Miguel A ^a   González Juanatey, Carlos ^b   Llorca, Javier ^c  

^a Division of Epidemiology   (Spain)

^b HOSPITAL UNIVERSITARIO LUCUS AUGUSTI   (Spain)

^c UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL ACTIVATION; COMORBIDITY; DISEASE ACTIVITY; DISEASE DURATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; INFLAMMATION; LETTER; MORTALITY; POLYARTHRITIS; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; SUBCLINICAL ATHEROSCLEROSIS;

ATHEROSCLEROSIS; INFLAMMATION; PSORIATIC ARTHRITIS;

ARTHRITIS, PSORIATIC; CARDIOVASCULAR DISEASES; HUMANS;

EID: 84897976675     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-205154     Document Type: Letter

References (10)

1. Jamnitski A, Symmons D, Peters MJL, et al. Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review. Ann Rheum Dis 2013;72:211-16.
2. Del Rincon I, O'Leary DH, Freeman GL, et al. Acceleration of atherosclerosis during the course of rheumatoid arthritis. Atherosclerosis 2007;195:354-60. (Pubitemid 350087940)
3. Gonzalez-Gay MA, Gonzalez-Juanatey C, Martin J. Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin Arthritis Rheum 2005;35:8-17. (Pubitemid 41111466)
4. Sattar N, McCarey DW, Capell H, et al. Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis [review]. Circulation 2003;108:2957-63. (Pubitemid 37553561)
5. Del Rincón I, Williams K, Stern MP, et al. Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum 2003;48:1833-40. (Pubitemid 36828677)
6. Gonzalez-Gay MA, Gonzalez-Juanatey C, Lopez-Diaz MJ, et al. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum 2007;57:125-32.
7. Gonzalez-Juanatey C, Llorca J, Miranda-Filloy JA, et al. Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum 2007;57:287-93. (Pubitemid 47164092)
8. Gonzalez-Juanatey C, Llorca J, Amigo-Diaz E, et al. High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum 2007;57:1074-80. (Pubitemid 47237336)
9. Goodson NJ, Symmons DP, Scott DG, et al. Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort. Arthritis Rheum 2005;52:2293-9. (Pubitemid 41117412)
10. González-Juanatey C, Llorca J, González-Gay MA. Correlation between endothelial function and carotid atherosclerosis in rheumatoid arthritis patients with long-standing disease. Arthritis Res Ther 2011;13:R101.